Data showed that the combo reduced the risk of metastasis or death by 58% compared to a placebo regimen. At an interim analysis with a median follow-up of 3.8 years, the hazard ratio (HR) for ...

Pancreatic cancer cells may depend on a protein that helps them take in the fuel needed to grow. Researchers at the Francis ...

Dr. Keith Roach explains why doctors do not recommend routine pancreatic cancer screening for average risk adults.

Expanding on the unprecedented final results previously reported from the Phase 3 RASolute 302 trial, the exploratory subgroup analyses showed ...

Despite being one of the deadliest cancers, pancreatic screening carries more risks than benefits for average-risk patients, ...

Experts advise against routine pancreatic cancer screening for average-risk individuals, as false positives, radiation risks ...

Experts say screening average-risk patients causes more harm than good, though high-risk individuals may benefit.

Dear Doctor Roach: Please explain why there are standard tests that we all know we should do as we age, such as a colonoscopy ...

Pancreatic cancer lacks standard screening due to low prevalence, imperfect tests, and poor outcomes even when caught early, ...

Experts say a new class of cancer drugs could change the calculus on early detection if outcomes for early-stage patients ...

He had an MRI, which found a mass in the tail of pancreas. We’re awaiting biopsy results now, but we know it’s a small mass ...

Experts say screening average-risk patients does more harm than good — but one couple's persistence changed everything.